ENLVVSNRSN• 12 Months (Normalized)
ENLV vs NRSN (Enlivex Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ENLV Performance $0.57
-96.29%
Enlivex Ltd.
Normalized Baseline0.00%
NRSN Performance $7.4
+%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-96.29 pts
NRSN outperforming by 96.29 percentage points
ENLVNRSN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ENLV NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ENLV Price | ENLV Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $0.57 | -96.29% | $- | - | |
| Sep 23, 2026 | $0.64 | -95.86% | $7.40 | +527.12% | -622.98% |
| Sep 22, 2026 | $- | $7.18 | +508.47% | - | |
| Sep 21, 2026 | $0.69 | -95.51% | $6.62 | +461.02% | -556.53% |
| Sep 18, 2026 | $0.81 | -94.78% | $6.35 | +438.14% | -532.92% |
| Sep 17, 2026 | $0.73 | -95.29% | $6.72 | +469.49% | -564.78% |
| Sep 16, 2026 | $0.81 | -94.75% | $6.49 | +450.00% | -544.75% |
| Sep 15, 2026 | $0.88 | -94.28% | $7.03 | +495.76% | -590.04% |
| Sep 14, 2026 | $0.86 | -94.40% | $6.90 | +484.75% | -579.15% |
| Sep 11, 2026 | $0.96 | -93.79% | $0.35 | -70.59% | -23.20% |
| Sep 10, 2026 | $0.98 | -93.65% | $0.33 | -71.86% | -21.79% |
| Sep 09, 2026 | $1.04 | -93.27% | $0.40 | -66.02% | -27.25% |
| Sep 08, 2026 | $1.11 | -92.82% | $0.42 | -64.58% | -28.24% |
| Sep 04, 2026 | $1.10 | -92.88% | $0.51 | -56.69% | -36.19% |
| Sep 03, 2026 | $1.16 | -92.49% | $0.40 | -65.93% | -26.56% |
Page 1 of 17